BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18423425)

  • 1. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
    Sharf R; Sarhan M; Dileone RJ
    Biol Psychiatry; 2008 Aug; 64(3):175-83. PubMed ID: 18423425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.
    Richardson KA; Aston-Jones G
    J Neurosci; 2012 Mar; 32(11):3809-17. PubMed ID: 22423101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal.
    Laorden ML; Ferenczi S; Pintér-Kübler B; González-Martín LL; Lasheras MC; Kovács KJ; Milanés MV; Núñez C
    PLoS One; 2012; 7(5):e36871. PubMed ID: 22590628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.
    Sharf R; Guarnieri DJ; Taylor JR; DiLeone RJ
    Brain Res; 2010 Mar; 1317():24-32. PubMed ID: 20034477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.
    Georgescu D; Zachariou V; Barrot M; Mieda M; Willie JT; Eisch AJ; Yanagisawa M; Nestler EJ; DiLeone RJ
    J Neurosci; 2003 Apr; 23(8):3106-11. PubMed ID: 12716916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
    Zhou Y; Cui CL; Schlussman SD; Choi JC; Ho A; Han JS; Kreek MJ
    Neuroscience; 2008 Jun; 153(4):1225-34. PubMed ID: 18436386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons.
    Vittoz NM; Schmeichel B; Berridge CW
    Eur J Neurosci; 2008 Oct; 28(8):1629-40. PubMed ID: 18973582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lateral hypothalamic orexin neurons in reward processing and addiction.
    Aston-Jones G; Smith RJ; Moorman DE; Richardson KA
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):112-21. PubMed ID: 18655797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute high fat diet consumption activates the mesolimbic circuit and requires orexin signaling in a mouse model.
    Valdivia S; Patrone A; Reynaldo M; Perello M
    PLoS One; 2014; 9(1):e87478. PubMed ID: 24466352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
    Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
    Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
    Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
    Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal.
    Plaza-Zabala A; Flores Á; Maldonado R; Berrendero F
    Biol Psychiatry; 2012 Feb; 71(3):214-23. PubMed ID: 21831361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.
    Davoudi M; Vijeepallam K; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Neural Transm (Vienna); 2019 Nov; 126(11):1425-1435. PubMed ID: 31493096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
    Kourosh-Arami M; Joghataei MT; Komaki A; Gholami M; Najafi Z; Lavaie M
    Int J Neurosci; 2022 Jan; 132(1):67-76. PubMed ID: 32746675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
    Zarepour L; Fatahi Z; Sarihi A; Haghparast A
    Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
    Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
    Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats.
    Mousavi Y; Azizi H; Mirnajafi-Zadeh J; Javan M; Semnanian S
    Neurosci Lett; 2014 Aug; 578():90-4. PubMed ID: 24970749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.